CREWE ADVISORS LLC Vertex Pharmaceuticals Incorporated Transaction History

CREWE ADVISORS LLC portfolio value:

$206,000
portfolio value

CREWE ADVISORS LLC quarter portfolio value change:

+2.75%
quarter

Vertex Pharmaceuticals Incorporated 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +5.49% 37 shares 16K $289.54 711
Q2 2022 share Increase +44.95% 209 shares 69K $281.79 674
Q1 2022 share Increase +220.69% 320 shares 89K $260.97 465
Q4 2021 share Increase 0.00% 145 shares 32K $222.45 145
Q4 2020 share Decrease -100.00% -30 shares -8K $236.34 0
Q3 2020 share Increase 0.00% 30 shares 8K $272.12 30